Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Related Citations for PubMed (Select 22345679)

1.

Reduced positive affect (anhedonia) is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry.

Damen NL, Pelle AJ, Boersma E, Serruys PW, van Domburg RT, Pedersen SS.

Eur J Prev Cardiol. 2013 Feb;20(1):127-34. doi: 10.1177/2047487312436452. Epub 2012 Jan 16.

PMID:
22345679
2.

Depression is independently associated with 7-year mortality in patients treated with percutaneous coronary intervention: results from the RESEARCH registry.

Damen NL, Versteeg H, Boersma E, Serruys PW, van Geuns RJ, Denollet J, van Domburg RT, Pedersen SS.

Int J Cardiol. 2013 Sep 10;167(6):2496-501. doi: 10.1016/j.ijcard.2012.04.028. Epub 2012 May 3.

PMID:
22560933
3.

Reduced positive affect (anhedonia) predicts major clinical events following implantation of coronary-artery stents.

Denollet J, Pedersen SS, Daemen J, de Jaegere P, Serruys PW, van Domburg RT.

J Intern Med. 2008 Feb;263(2):203-11. Epub 2007 Dec 5.

PMID:
18069998
4.

Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients.

Halkin A, Selzer F, Marroquin O, Laskey W, Detre K, Cohen H.

J Invasive Cardiol. 2006 Dec;18(12):577-83.

PMID:
17197706
5.

Anhedonia is associated with poor health status and more somatic and cognitive symptoms in patients with coronary artery disease.

Pelle AJ, Pedersen SS, Erdman RA, Kazemier M, Spiering M, van Domburg RT, Denollet J.

Qual Life Res. 2011 Jun;20(5):643-51. doi: 10.1007/s11136-010-9792-4. Epub 2010 Nov 17.

6.

Incidence and multivariable correlates of long-term mortality in patients treated with surgical or percutaneous revascularization in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial.

Farooq V, Serruys PW, Bourantas C, Vranckx P, Diletti R, Garcia Garcia HM, Holmes DR, Kappetein AP, Mack M, Feldman T, Morice MC, Colombo A, Morel MA, de Vries T, van Es GA, Steyerberg EW, Dawkins KD, Mohr FW, James S, Ståhle E.

Eur Heart J. 2012 Dec;33(24):3105-13. doi: 10.1093/eurheartj/ehs367. Epub 2012 Oct 26.

7.

Obesity, health status, and 7-year mortality in percutaneous coronary intervention: in search of an explanation for the obesity paradox.

Younge JO, Damen NL, van Domburg RT, Pedersen SS.

Int J Cardiol. 2013 Aug 20;167(4):1154-8. doi: 10.1016/j.ijcard.2012.03.105. Epub 2012 Apr 3.

PMID:
22475846
8.

Adverse clinical events in patients treated with sirolimus-eluting stents: the impact of Type D personality.

Pedersen SS, Denollet J, Ong AT, Sonnenschein K, Erdman RA, Serruys PW, van Domburg RT.

Eur J Cardiovasc Prev Rehabil. 2007 Feb;14(1):135-40.

PMID:
17301639
9.

Negative and positive affect are independently associated with patient-reported health status following percutaneous coronary intervention.

Versteeg H, Pedersen SS, Erdman RA, van Nierop JW, de Jaegere P, van Domburg RT.

Qual Life Res. 2009 Oct;18(8):953-60. doi: 10.1007/s11136-009-9511-1. Epub 2009 Jul 19.

10.

The adverse long-term impact of renal impairment in patients undergoing percutaneous coronary intervention in the drug-eluting stent era.

Appleby CE, Ivanov J, Lavi S, Mackie K, Horlick EM, Ing D, Overgaard CB, Seidelin PH, von Harsdorf R, Dzavík V.

Circ Cardiovasc Interv. 2009 Aug;2(4):309-16. doi: 10.1161/CIRCINTERVENTIONS.108.828954. Epub 2009 Jun 30.

11.

Comparison between sirolimus- and paclitaxel-eluting stents for the treatment of older patients affected by coronary artery disease: results from a single-center allcomers registry.

Buja P, Lanzellotti D, Isabella G, Napodano M, Panfili M, Favaretto E, Iliceto S, Tarantini G.

Heart Vessels. 2012 Nov;27(6):553-8. doi: 10.1007/s00380-011-0194-5. Epub 2011 Oct 12.

PMID:
21989862
12.

Clustering of psychosocial risk factors enhances the risk of depressive symptoms 12-months post percutaneous coronary intervention.

Pedersen SS, Denollet J, van Gestel YR, Serruys PW, van Domburg RT.

Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):203-9. doi: 10.1097/HJR.0b013e3282f19d2f.

PMID:
18391649
13.

Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.

Ashrith G, Lee VV, Elayda MA, Reul RM, Wilson JM.

Am J Cardiol. 2010 Aug 1;106(3):348-53. doi: 10.1016/j.amjcard.2010.03.037. Epub 2010 Jun 18.

PMID:
20643244
14.

Multicenter international registry of unprotected left main coronary artery percutaneous coronary intervention with drug-eluting stents in patients with myocardial infarction.

Lee MS, Sillano D, Latib A, Chieffo A, Zoccai GB, Bhatia R, Sheiban I, Colombo A, Tobis J.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):15-21. doi: 10.1002/ccd.21712.

PMID:
19089930
15.

Multivessel drug-eluting stenting and impact of diabetes mellitus--a report from the EVENT registry.

Novack V, Tsyvine D, Cohen DJ, Pencina M, Dubin J, Dehghani H, Kleiman NS, Cutlip DE.

Catheter Cardiovasc Interv. 2009 Jun 1;73(7):874-80. doi: 10.1002/ccd.21925.

PMID:
19180665
16.

The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.

Ong AT, Serruys PW, Aoki J, Hoye A, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sonnenschein K, Regar E, van der Ent M, de Jaegere PP, McFadden EP, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT.

J Am Coll Cardiol. 2005 Apr 5;45(7):1135-41.

17.

In-hospital and 1-year outcomes with drug-eluting versus bare metal stents in saphenous vein graft intervention: a report from the EVENT registry.

Tolerico PH, Cohen DJ, Kleiman NS, Berger PB, Brilakis ES, Piana RN, Shammo S, Keyes MJ, Kennedy KF, Massaro JM, Saucedo JF; EVENT Investigators.

Catheter Cardiovasc Interv. 2012 Dec 1;80(7):1127-36. doi: 10.1002/ccd.24352. Epub 2012 May 4.

PMID:
22431166
18.

Outcomes after percutaneous coronary intervention of ostial lesions in the era of drug-eluting stents.

Freeman M, Clark DJ, Andrianopoulos N, Duffy SJ, Lim HS, Brennan A, Charter K, Shaw J, Horrigan M, Ajani AE, Sebastian M, Reid CM, Farouque HM; Melbourne Interventional Group.

Catheter Cardiovasc Interv. 2009 May 1;73(6):763-8. doi: 10.1002/ccd.21941.

PMID:
19309731
19.

Comparison of five-year outcome of octogenarians undergoing percutaneous coronary intervention with drug-eluting versus bare-metal stents (from the RESEARCH and T-SEARCH Registries).

Cheng JM, Onuma Y, Piazza N, Nuis RJ, Van Domburg RT, Serruys PW; Interventional Cardiologists of Thoraxcenter (2000-2009).

Am J Cardiol. 2010 Nov 15;106(10):1376-81. doi: 10.1016/j.amjcard.2010.07.007. Epub 2010 Oct 1.

PMID:
21059424
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk